REPLIGEN CORP (RGEN) Shareholders’ equity 2016–2025
REPLIGEN CORP (RGEN) shareholders’ equity at each fiscal year-end, per SEC filings.
$2.1BFY2025 · since FY2016: $168.8M → $2.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.1B | +6.8% |
| FY2024 | $2.0B | +0.4% |
| FY2023 | $2.0B | +2.8% |
| FY2022 | $1.9B | +9.2% |
| FY2021 | $1.8B | +14.4% |
| FY2020 | $1.5B | +44.3% |
| FY2019 | $1.1B | +72.2% |
| FY2018 | $615.6M | +4.1% |
| FY2017 | $591.5M | +250.5% |
| FY2016 | $168.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice